Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3h0v | M2T | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3h0v | M2T | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 1.000 | |
3h0w | N8M | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.712 | |
3dz7 | O8M | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.675 | |
1i7c | MGB | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.644 | |
3dz4 | C8M | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.624 | |
3dz6 | M8E | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.623 | |
3dz2 | A8M | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.592 | |
2ejz | SAH | Diphthine synthase | / | 0.498 | |
1i7m | CG | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.496 | |
1u65 | CP0 | Acetylcholinesterase | 3.1.1.7 | 0.492 | |
4ara | C56 | Acetylcholinesterase | 3.1.1.7 | 0.490 | |
1g63 | FMN | Epidermin decarboxylase | 4.1.1 | 0.483 | |
4b7z | Q4Q | Acetylcholinesterase | 3.1.1.7 | 0.478 | |
1w4l | GL8 | Acetylcholinesterase | 3.1.1.7 | 0.477 | |
2w6c | BM4 | Acetylcholinesterase | 3.1.1.7 | 0.477 | |
4ey7 | E20 | Acetylcholinesterase | 3.1.1.7 | 0.476 | |
4u14 | 0HK | Muscarinic acetylcholine receptor M3 | / | 0.472 | |
2j3q | TFL | Acetylcholinesterase | 3.1.1.7 | 0.471 | |
1eve | E20 | Acetylcholinesterase | 3.1.1.7 | 0.469 | |
1h22 | E10 | Acetylcholinesterase | 3.1.1.7 | 0.469 | |
3rsv | 3RS | Beta-secretase 1 | 3.4.23.46 | 0.469 | |
2g8y | NAD | Hydroxycarboxylate dehydrogenase B | / | 0.467 | |
4cdm | FO1 | Deoxyribodipyrimidine photolyase | / | 0.467 | |
3ojw | FMN | NADPH--cytochrome P450 reductase | / | 0.466 | |
3to3 | ATP | Petrobactin biosynthesis protein AsbB | / | 0.462 | |
3zc3 | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.462 | |
1q84 | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.461 | |
2q1s | NAI | Putative nucleotide sugar epimerase/ dehydratase | / | 0.461 | |
2zev | IPE | Geranylgeranyl pyrophosphate synthase | / | 0.461 | |
2e9a | B28 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.459 | |
1i5r | HYC | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.458 | |
4c2z | 646 | Glycylpeptide N-tetradecanoyltransferase 1 | / | 0.458 | |
4acu | QN7 | Beta-secretase 1 | 3.4.23.46 | 0.456 | |
4b1e | 6T6 | Beta-secretase 1 | 3.4.23.46 | 0.456 | |
2fut | H1S | Heparin and heparin-sulfate lyase | / | 0.455 | |
2nmt | MIM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.455 | |
4wbd | ADP | Putative cysteine ligase BshC | / | 0.455 | |
1k9s | FM1 | Purine nucleoside phosphorylase DeoD-type | / | 0.454 | |
4a30 | QMI | Glycylpeptide N-tetradecanoyltransferase | / | 0.454 | |
4e90 | 7RG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.454 | |
4u16 | 3C0 | Muscarinic acetylcholine receptor M3 | / | 0.454 | |
1tco | FK5 | Peptidyl-prolyl cis-trans isomerase FKBP1A | 5.2.1.8 | 0.453 | |
1tco | FK5 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 3.1.3.16 | 0.453 | |
1vbi | NAD | Malate/L-lactate dehydrogenase family protein | / | 0.453 | |
2x06 | NAD | L-sulfolactate dehydrogenase | / | 0.453 | |
3hdy | GDU | UDP-galactopyranose mutase | / | 0.453 | |
4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.453 | |
4arb | C57 | Acetylcholinesterase | 3.1.1.7 | 0.453 | |
4b77 | 54M | Beta-secretase 1 | 3.4.23.46 | 0.453 | |
4bft | ZVT | Pantothenate kinase | 2.7.1.33 | 0.453 | |
1ut6 | A8N | Acetylcholinesterase | 3.1.1.7 | 0.452 | |
1x1b | SAH | C-20 methyltransferase | / | 0.452 | |
4da8 | BG2 | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.452 | |
4g2j | 0WF | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.452 | |
4j7g | TRH | PCZA361.3 | / | 0.451 | |
2xuq | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.450 | |
3buv | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.450 | |
4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.450 | |
1amo | FMN | NADPH--cytochrome P450 reductase | / | 0.449 | |
3sqz | COA | Putative hydroxymethylglutaryl-CoA synthase | / | 0.449 | |
4kfq | KFQ | Glutamate receptor ionotropic, NMDA 1 | / | 0.449 | |
2ea4 | F79 | Methionine aminopeptidase 2 | / | 0.448 | |
3br3 | ET | HTH-type transcriptional regulator QacR | / | 0.448 | |
3hii | PNT | Amiloride-sensitive amine oxidase [copper-containing] | / | 0.448 | |
3n0b | FAD | Flavin-dependent thymidylate synthase | 2.1.1.148 | 0.448 | |
5dp2 | NAP | CurF | / | 0.448 | |
2g28 | TDK | Pyruvate dehydrogenase E1 component | 1.2.4.1 | 0.447 | |
4a31 | 2CB | Glycylpeptide N-tetradecanoyltransferase | / | 0.447 | |
4a81 | DXC | Major pollen allergen Bet v 1-A | / | 0.447 | |
4j7h | TRH | PCZA361.3 | / | 0.447 | |
4kq6 | DLZ | 6,7-dimethyl-8-ribityllumazine synthase | / | 0.447 | |
1h60 | STR | Pentaerythritol tetranitrate reductase | / | 0.446 | |
2ha6 | SCK | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
2xi4 | AFT | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
3vo2 | FAD | Ferredoxin--NADP reductase | / | 0.446 | |
1ps9 | MDE | 2,4-dienoyl-CoA reductase | 1.3.1.34 | 0.445 | |
2cns | ACO | Ribosomal-protein-alanine acetyltransferase | / | 0.445 | |
2h44 | 7CA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.445 | |
2vf3 | GVS | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | / | 0.445 | |
3dys | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.445 | |
3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.445 | |
3qgf | 46F | Genome polyprotein | 2.7.7.48 | 0.445 | |
4m0f | 1YK | Acetylcholinesterase | 3.1.1.7 | 0.445 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.444 | |
1jdz | FMB | Purine nucleoside phosphorylase | / | 0.444 | |
2a57 | CRM | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.444 | |
2fjm | 073 | Tyrosine-protein phosphatase non-receptor type 1 | 3.1.3.48 | 0.444 | |
2ok8 | FAD | Ferredoxin--NADP reductase, apicoplast | / | 0.444 | |
3ada | NAD | Subunit alpha of sarocosine oxidase | / | 0.444 | |
4bfx | ZVX | Pantothenate kinase | 2.7.1.33 | 0.444 | |
4zzi | 1NS | NAD-dependent protein deacetylase sirtuin-1 | 3.5.1 | 0.444 | |
1zgb | A1E | Acetylcholinesterase | 3.1.1.7 | 0.443 | |
3hl0 | NAD | Maleylacetate reductase | / | 0.443 | |
1yc2 | NAD | NAD-dependent protein deacylase 2 | / | 0.442 | |
2b99 | RDL | Riboflavin synthase | 2.5.1.9 | 0.442 | |
2xys | SY9 | Soluble acetylcholine receptor | / | 0.442 | |
2zrz | FNR | Isopentenyl-diphosphate delta-isomerase | / | 0.442 | |
3jsx | CC2 | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
3l3l | L3L | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.442 | |
3n3z | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
3zdn | FAD | Monoamine oxidase N | 1.4.3.4 | 0.442 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
1gaw | FAD | Ferredoxin | / | 0.441 | |
1isg | AGS | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 | 3.2.2.6 | 0.441 | |
1ja1 | FMN | NADPH--cytochrome P450 reductase | / | 0.441 | |
2e8u | IPE | Geranylgeranyl pyrophosphate synthase | / | 0.441 | |
2rcw | AAI | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.441 | |
3cb2 | GDP | Tubulin gamma-1 chain | / | 0.441 | |
3uzw | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.441 | |
1w6r | GNT | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.440 | |
3bv7 | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.440 | |
3jsw | JAR | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.440 | |
4b14 | 4XB | Glycylpeptide N-tetradecanoyltransferase | / | 0.440 | |
4krs | 1SX | Tankyrase-1 | 2.4.2.30 | 0.440 |